Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

ClinicalTrials.gov ID: NCT01353248

Public ClinicalTrials.gov record NCT01353248. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Open-Label Study of GS-5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) to Treatment-Naive Subjects With Chronic Genotype 1 HCV Infection

Study identification

NCT ID
NCT01353248
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
141 participants

Conditions and interventions

Interventions

  • GS-5885 Drug
  • Tegobuvir Drug
  • GS-9451 Drug
  • ribavirin tablet Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2011
Primary completion
Sep 30, 2012
Completion
Feb 28, 2013
Last update posted
Dec 19, 2013

2011 – 2013

United States locations

U.S. sites
42
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Birmingham Gastroenterology Associates, P.C. Birmingham Alabama 35209
Digestive Health Specialists of the Southeast Dothan Alabama 36305
Advanced Clinical Research Institute Anaheim California 92801
Southern California Liver Centers Coronado California 92118
UCSF Fresno Medical Education Program (MEP) Fresno California 93721
Stanford University School of Medicine Palo Alto California 94304
University of California San Diego San Diego California 92103
Kaiser Permanente San Diego California 92154
UCSF San Francisco California 94143
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307
Bach and Godofsky Infectious Diseases Bradenton Florida 34209
University of Florida - Gainesville Gainesville Florida 32610
Borland-Groover Clinic Jacksonville Florida 32256
University of Miami School of Medicine Miami Florida 33136
Orlando Immunology Center Orlando Florida 32803
Orlando Clinical Research Center Orlando Florida 32809
Gastrointestinal Specialists of Georgia PC Marietta Georgia 30060
University of Chicago Chicago Illinois 60637
Indiana University Indianapolis Indiana 46202
Private Practice Opelousas Louisiana 70570
Johns Hopkins University Lutherville Maryland 21093
Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center Boston Massachusetts 02115
Henry Ford Health System Detroit Michigan 48202
Gastrointestinal Associates, PA Jackson Mississippi 39202
University of New Mexico Albuquerque New Mexico 87131
Mount Sinai Medical Center New York New York 10029
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7584
Duke University Medical Center Durham North Carolina 27710
Cleveland Clinic Cleveland Ohio 44195
Options Health Research, LLC Tulsa Oklahoma 74104
University of Pennsylvania Hospital Philadelphia Pennsylvania 19104
Gastro One Germantown Tennessee 38138
Memphis Gastroenterology Group Germantown Tennessee 38138
Columbia Medical Group, The Frist Clinic Nashville Tennessee 37203
Nashville Gastrointestinal Specialists, Inc Nashville Tennessee 37211
Baylor University Medical Center Dallas Texas 75246
Research Specialists of Texas Houston Texas 77030
Alamo Medical Research San Antonio Texas 78215
Lifetree Clinical Research, LC Salt Lake City Utah 84106
Inova Fairfax Hospital - Center for Liver Diseases Falls Church Virginia 22042
Liver Institute of Virginia, Bon Secours Health System Newport News Virginia 23602

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01353248, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 19, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01353248 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →